Polypyridiniums with Inherent Autophagy‐Inducing Activity for Atherosclerosis Treatment by Intracellularly Co‐Delivering Two Antioxidant Enzymes
Advanced Materials · 2024
DOI: 10.1002/adma.202409015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Mengxiao Liang und 9 weiteren Autor:innen. Beteiligte Einrichtung: South China Advanced Institute for Soft Matter Science and Technology, School of Emergent Soft Matter, South China University of Technology, Guangzho…. Hauptthemen laut MEDLINE: Atherosclerosis, Autophagy, Catalase, Antioxidants. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Key R&D Program of China, Synthetic Biology Research, National Natural Science Foundation of China, Basic Research Program of Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Atherosclerosis is a chronic inflammatory disease of the arterial intima and is becoming the leading cause of morbidity and mortality worldwide. There is considerable evidence that defective autophagy and overproduction of reactive oxygen species (ROS) are closely involved in the development and progression of atherosclerosis. Here, a polymer is developed with the inherent autophagy‐inducing activity to treat atherosclerosis by co‐delivering antioxidant enzymes. The lead material P5c screened from a library of polypyridiniums shows robust efficacy in cytosolic protein delivery, and efficiently delivers superoxide dismutase (SOD) and catalase (CAT) into macrophages to down‐regulate intracellular ROS. Moreover, P5c activates autophagy in macrophages and sufficiently inhibits foam cell formation. The P5c nanoparticle loaded with both SOD and CAT is further coated with neutrophil membranes to treat atherosclerosis in an ApoE −/− mice model. The treatment exhibits potent anti‐atherosclerosis effect via activating autophagy, decreasing the infiltration of senescent cells in atherosclerotic plaques, regulating the M2 polarization of macrophages, and restoring the structure and function of splenic corpuscles. The polymer offers a multifaceted approach to combat atherosclerosis, addressing both cellular dysfunction and the need for targeted protein delivery within affected cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- South China Advanced Institute for Soft Matter Science and Technology, School of Emergent Soft Matter, South China University of Technology, Guangzhou, 510640, China.
- Department of Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201999, China.
- Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai, 200241, China.
- Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
ORCID-Profile: Yiyun Cheng
Förderung
- National Key R&D Program of China, Synthetic Biology Research
- National Natural Science Foundation of China
- Basic Research Program of Science and Technology Commission of Shanghai Municipality
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Liang, M., Wang, Q., Zhang, S., Lan, Q., Wang, R., Tan, E., Zhou, L., Wang, C., Wang, H., & Cheng, Y. (2024). Polypyridiniums with Inherent Autophagy‐Inducing Activity for Atherosclerosis Treatment by Intracellularly Co‐Delivering Two Antioxidant Enzymes. Advanced Materials. https://doi.org/10.1002/adma.202409015
Vancouver
Liang M, Wang Q, Zhang S, Lan Q, Wang R, Tan E, et al. Polypyridiniums with Inherent Autophagy‐Inducing Activity for Atherosclerosis Treatment by Intracellularly Co‐Delivering Two Antioxidant Enzymes. Advanced Materials. 2024. doi:10.1002/adma.202409015
BibTeX
@article{Liang2024,
author = {Liang, Mengxiao and Wang, Qian and Zhang, Song and Lan, Qi and Wang, Ruijue and Tan, Echuan and Zhou, Lei and Wang, Changping and Wang, Hui and Cheng, Yiyun},
title = {Polypyridiniums with Inherent Autophagy‐Inducing Activity for Atherosclerosis Treatment by Intracellularly Co‐Delivering Two Antioxidant Enzymes},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202409015}
}
EUVIMED